Tan A. Ince, MD, Ph.D.

Insurances Accepted

For relevant information regarding accepted insurances, please contact this provider directly.

Personal Statement

Dr. Tan A. Ince is a physician-scientist who is board certified in anatomic pathology, with subspecialty training in breast pathology with Dr. Lester and gynecologic pathology with Dr.  Crum at the Brigham and Women’s Hospital. Having trained with Robert Weinberg at MIT, Dr. Ince gained expertise in the role of normal cell-of-origin of human cancers, as well as epigenomics, cancer stem cells, and endocrine receptors in the development of tumorigenesis. Dr. Ince developed a breast cancer classification system based on normal cellular lineages, characterized by combinatorial expression of various hormone receptors. His laboratory was among the first to identify Histone Deacetylase 7 (HDAC7) and Heat shock factor 1 (HSF1) as a key components of Cancer Stem Cell (CSC) epigenomic regulation. Dr. Ince has been involved in the development of micro-devices for medical applications, and invented various nutrient media for patient derived breast, ovary, fallopian tube and leukemia cell cultures. Dr. Ince has been awarded several nutrient media patents and the cell lines established by his laboratory have been used by other investigators around the world.

Biographical Info

Dr. Ince received his MD at Hacettepe University School of Medicine in Ankara, Turkey in 1988 and his Ph.D. in 1996 at Cornell University in New York, NY. He completed his  post-doctoral training at Sloan-Kettering Cancer Center, residency at Massachusetts General Hospital and fellowship at Brigham and Women’s Hospital, Harvard Medical School. In 2001, he became a Visiting Clinical Scholar at the Whitehead Institute/Massachusetts Institute of Technology and Instructor at Harvard Medical School. Dr. Ince was promoted to Assistant Professor at Harvard Medical School (2008) and Professor at the University of Miami, Miller School of Medicine (2018). Since 2020, Dr. Ince has been the Pathologist-in-Chief at New York Presbyterian, Brooklyn Methodist Hospital and a Vice-chair at Weill Cornell Department of Pathology and Laboratory Medicine.


Board Certifications
American Board of Pathology
Clinical Expertise
Breast Pathology
Laboratory Medicine
  • Ph.D.
    Cornell University
  • M.D.
    Hacettepe University Faculty of Medicine (Turkey)
  • Attending Pathologist
    NewYork-Presbyterian/Brooklyn Methodist Hospital
  • Attending Pathologist
    NewYork-Presbyterian Hospital
  • Professor of Pathology and Laboratory Medicine
    Weill Cornell Medical College, Cornell University

Relationships and collaborations with for-profit and not-for profit organizations are of vital importance to our faculty because these exchanges of scientific information foster innovation. As experts in their fields, WCM physicians and scientists are sought after by many organizations to consult and educate. WCM and its faculty make this information available to the public, thus creating a transparent environment.

Proprietary Interest: 
GLG Pharma
United States Biological